Long-term effect of molsidomine and pentaerythrityl tetranitrate on cardiovascular system of spontaneously hypertensive rats
Jazyk angličtina Země Česko Médium print
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
PubMed
14640892
Knihovny.cz E-zdroje
- MeSH
- aorta thoracica účinky léků patologie MeSH
- aorta účinky léků enzymologie MeSH
- arteriae carotides účinky léků patologie MeSH
- časové faktory MeSH
- donory oxidu dusnatého farmakologie MeSH
- guanosinmonofosfát cyklický metabolismus MeSH
- hypertenze farmakoterapie patologie patofyziologie MeSH
- kardiovaskulární systém účinky léků patologie patofyziologie MeSH
- koronární cévy účinky léků patologie MeSH
- krevní tlak účinky léků MeSH
- krysa rodu Rattus MeSH
- molsidomin farmakologie MeSH
- náhodné rozdělení MeSH
- pentaerythritoltetranitrát farmakologie MeSH
- potkani inbrední SHR MeSH
- potkani Wistar MeSH
- srdeční frekvence účinky léků MeSH
- synthasa oxidu dusnatého metabolismus MeSH
- tělesná hmotnost účinky léků MeSH
- trombocyty účinky léků metabolismus MeSH
- vazodilatancia farmakologie MeSH
- velikost orgánu účinky léků MeSH
- výsledek terapie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Názvy látek
- donory oxidu dusnatého MeSH
- guanosinmonofosfát cyklický MeSH
- molsidomin MeSH
- pentaerythritoltetranitrát MeSH
- synthasa oxidu dusnatého MeSH
- vazodilatancia MeSH
We studied the effects of long-term administration of molsidomine and pentaerythrityl tetranitrate (PETN) on the cardiovascular system of spontaneously hypertensive rats (SHR). One control and three experimental groups of 10-week-old animals were used: 1) control Wistar rats, 2) SHR, 3) SHR treated with molsidomine in tap water (100 mg/kg/day, by gavage), and 4) SHR treated with PETN in tap water (200 mg/kg/day, by gavage). After six weeks, the content of cGMP in platelets and NO synthase (NOS) activity in aortas were evaluated in the experimental groups. For morphological evaluation the rats were perfused at 120 mm Hg with a glutaraldehyde fixative and the arteries were processed for electron microscopy. Blood pressure and heart weight/body weight ratio (HW/BW) were increased in all experimental groups with respect to the controls. HW/BW was lower in the molsidomine group in comparison to both SHR and PETN-treated group. The platelet content of cGMP was increased and the activity of NOS in the aortas was decreased in the molsidomine and PETN-treated groups. Wall thickness and cross-sectional area of thoracic aorta, carotid artery and coronary artery were increased similarly in all experimental groups compared to the controls, but there were no differences among the experimental groups. We summarize that long-term administration of exogenous NO donors did not improve pathological changes of the cardiovascular system in SHR.